Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ: AVIR · IEX Real-Time Price · USD

3.690

-0.010 (-0.27%)

At close: Apr 25, 2024, 4:00 PM

3.720

+0.030 (0.81%)

After-hours: Apr 25, 2024, 5:17 PM EDT

Atea Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Revenue	0	0	351.37	48.63	0	0
Revenue Growth (YoY)	-	-	622.49%	-	-	-
Gross Profit	0	0	351.37	48.63	0	0
Selling, General & Admin	49.92	48.71	45.79	21.64	4.44	2.8
Research & Development	114.24	81.94	167.21	38.02	10.17	6.68
Operating Expenses	164.16	130.65	212.99	59.66	14.61	9.48
Operating Income	-164.16	-130.65	138.38	-11.03	-14.61	-9.48
Other Expense / Income	-29.22	-11.15	-0.21	-0.08	-0.57	-0.41
Pretax Income	-134.94	-119.5	138.59	-10.95	-14.03	-9.06
Income Tax	1.02	-3.59	17.4	0	0	0
Net Income	-135.96	-115.91	121.19	-10.95	-14.03	-9.06
Shares Outstanding (Basic)	83	83	83	22	10	10
Shares Outstanding (Diluted)	83	83	88	22	10	10
Shares Change	0.17%	-5.67%	308.70%	113.98%	0.52%	-
EPS (Basic)	-1.63	-1.39	1.46	-0.51	-1.39	-0.90
EPS (Diluted)	-1.63	-1.39	1.37	-0.51	-1.39	-0.90
Free Cash Flow	-85.4	-122.93	-87.01	296.71	-12.83	-7.92
Free Cash Flow Per Share	-1.02	-1.48	-1.05	13.74	-1.27	-0.79
Gross Margin	-	-	100.00%	100.00%	-	-
Operating Margin	-	-	39.38%	-22.68%	-	-
Profit Margin	-	-	34.49%	-22.51%	-	-
Free Cash Flow Margin	-	-	-24.76%	610.10%	-	-
Effective Tax Rate	-	-	12.56%	-	-	-
EBITDA	-134.52	-119.24	138.62	-10.93	-14.02	-9.05
EBITDA Margin	-	-	39.45%	-22.47%	-	-
Depreciation & Amortization	0.42	0.26	0.03	0.02	0.02	0.02
EBIT	-134.94	-119.5	138.59	-10.95	-14.03	-9.06
EBIT Margin	-	-	39.44%	-22.51%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).